Compounds > quinoxalines
Page last updated: 2024-08-17

quinoxalines and granisetron

quinoxalines has been researched along with granisetron in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (20.00)18.2507
2000's0 (0.00)29.6817
2010's4 (80.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Khan, NA; Poisson, JP1
Aoyama, T; Hattori, T; Kato, S; Kurosawa, S; Nahata, M; Ohno, S; Ro, S; Sakurada, T; Takabayashi, H; Tamai, M; Yakabi, K; Yuzurihara, M1
Bencherif, M; Lester, HA; Lummis, SC; Thompson, AJ1
de Esch, IJ; Lummis, SC; Thompson, AJ; Verheij, MH1
Lummis, SC; Thompson, AJ1

Other Studies

5 other study(ies) available for quinoxalines and granisetron

ArticleYear
5-HT3 receptor-channels coupled with Na+ influx in human T cells: role in T cell activation.
    Journal of neuroimmunology, 1999, Sep-01, Volume: 99, Issue:1

    Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Calcium Signaling; Cell Cycle; Enzyme Activation; Granisetron; Humans; Ion Channel Gating; Ion Transport; Jurkat Cells; Lymphocyte Activation; Metoclopramide; Neoplasm Proteins; Phytohemagglutinins; Piperazines; Protein Kinase C; Quinoxalines; Receptor, Serotonin, 5-HT1B; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Receptors, Serotonin, 5-HT3; Ryanodine; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Sodium; Sodium Channels; T-Lymphocytes; Thapsigargin

1999
Rikkunshito and 5-HT2C receptor antagonist improve cisplatin-induced anorexia via hypothalamic ghrelin interaction.
    Regulatory peptides, 2010, Apr-09, Volume: 161, Issue:1-3

    Topics: Animals; Anorexia; Cisplatin; Drugs, Chinese Herbal; Eating; Gastric Mucosa; Ghrelin; Granisetron; Hypothalamus; Male; Oligopeptides; Ondansetron; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, Ghrelin; Reverse Transcriptase Polymerase Chain Reaction; Serotonin 5-HT2 Receptor Antagonists; Stomach

2010
Varenicline is a potent agonist of the human 5-hydroxytryptamine3 receptor.
    The Journal of pharmacology and experimental therapeutics, 2011, Volume: 339, Issue:1

    Topics: Amino Acid Sequence; Animals; Benzazepines; Binding Sites; Dose-Response Relationship, Drug; Electrophysiological Phenomena; Granisetron; HEK293 Cells; Humans; Membrane Potentials; Mice; Models, Molecular; Molecular Sequence Data; Nicotinic Agonists; Oocytes; Patch-Clamp Techniques; Quinoxalines; Radioligand Assay; Receptors, Serotonin, 5-HT3; Serotonin 5-HT3 Receptor Agonists; Species Specificity; Varenicline; Xenopus laevis

2011
VUF10166, a novel compound with differing activities at 5-HT₃A and 5-HT₃AB receptors.
    The Journal of pharmacology and experimental therapeutics, 2012, Volume: 341, Issue:2

    Topics: Animals; Cells, Cultured; Female; Granisetron; HEK293 Cells; Humans; Isotope Labeling; Ligands; Mutation; Oocytes; Piperidines; Protein Binding; Quinoxalines; Receptors, Serotonin, 5-HT3; Serotonin 5-HT3 Receptor Agonists; Serotonin 5-HT3 Receptor Antagonists; Xenopus laevis

2012
A single channel mutation alters agonist efficacy at 5-HT3A and 5-HT3AB receptors.
    British journal of pharmacology, 2013, Volume: 170, Issue:2

    Topics: Animals; Dopamine; Drug Partial Agonism; Female; Granisetron; HEK293 Cells; Humans; Mutation; Oocytes; Patch-Clamp Techniques; Piperidines; Quinoxalines; Quipazine; Receptors, Serotonin, 5-HT3; Serotonin; Serotonin 5-HT3 Receptor Agonists; Time Factors; Xenopus laevis

2013